|
|
|
Insider
Information: |
Evnin Luke |
Relationship: |
10% Owner |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
330,044 |
|
Indirect Shares
|
35,767,143 |
|
|
Direct
Value |
$449,921 |
|
|
Indirect Value
|
$125,579,860 |
|
|
Total
Shares |
36,097,187 |
|
|
Total
Value |
$126,029,782 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-18.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Oscient Pharmaceuticals Corp |
OSCIQ |
Director |
|
0 |
2006-01-05 |
2,272,935 |
Premium* |
|
Idenix Pharmaceuticals Inc |
IDIX |
10% Owner |
2004-07-27 |
0 |
2004-07-27 |
4,797,991 |
Premium* |
|
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2004-07-02 |
0 |
2004-07-02 |
1,833,597 |
Premium* |
|
iPass Inc |
IPAS |
10% Owner |
2004-02-09 |
26,043 |
2004-02-09 |
262,533 |
Premium* |
|
Hemosense Inc |
HEM |
10% Owner |
2005-07-01 |
0 |
2007-11-06 |
0 |
Premium* |
|
American Cryostem Corporation |
CRYO |
10% Owner |
2005-07-13 |
0 |
2005-07-19 |
2,931,531 |
Premium* |
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
|
0 |
2016-09-27 |
3,887,502 |
Premium* |
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2013-06-13 |
0 |
2013-06-13 |
824,255 |
Premium* |
|
Syndax Pharmaceuticals Inc |
SNDX |
Director, 10% Owner |
2016-03-08 |
0 |
2016-03-08 |
2,168,691 |
Premium* |
|
Harpoon Therapeutics, Inc. |
HARP |
Former 10% Owner |
2019-02-12 |
0 |
2021-04-15 |
3,220,844 |
Premium* |
|
Repare Therapeutics Inc. |
RPTX |
10% Owner |
2020-06-23 |
0 |
2020-06-23 |
3,003,772 |
Premium* |
|
Oncorus, Inc. |
ONCR |
Director, 10% Owner |
|
0 |
2020-10-06 |
2,492,843 |
Premium* |
|
Turmeric Acquisition Corp. |
TMPM |
Chief Executive Officer |
2020-10-20 |
0 |
2020-10-20 |
415,500 |
Premium* |
|
Werewolf Therapeutics, Inc. |
HOWL |
Director, 10% Owner |
|
0 |
2021-05-04 |
4,284,172 |
Premium* |
|
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2023-05-22 |
304,001 |
2023-05-22 |
3,370,977 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
107 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
OSCIQ |
Oscient Pharmaceuticals C... |
officerTitle |
|
2005-12-29 |
4 |
AS |
$2.30 |
$11,270 |
I/I |
(4,900) |
2,362,835 |
|
- |
|
HARP |
Harpoon Therapeutics, Inc... |
Director |
|
2019-02-12 |
4 |
OE |
$0.05 |
$21,260 |
I/I |
432,119 |
4,275,949 |
0 |
- |
|
HARP |
Harpoon Therapeutics, Inc... |
Director |
|
2019-02-12 |
4 |
D |
$14.00 |
$21,336 |
I/I |
(1,524) |
4,274,425 |
0 |
- |
|
HARP |
Harpoon Therapeutics, Inc... |
Former 10% Owner |
|
2021-04-15 |
4 |
AS |
$20.49 |
$21,555 |
I/I |
(1,052) |
3,220,844 |
0 |
% |
|
HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
|
2021-01-26 |
4 |
AS |
$21.08 |
$28,732 |
I/I |
(1,363) |
4,339,955 |
0 |
% |
|
HARP |
Harpoon Therapeutics, Inc... |
Former 10% Owner |
|
2021-04-14 |
4 |
AS |
$20.06 |
$34,714 |
I/I |
(1,671) |
3,221,896 |
0 |
% |
|
HARP |
Harpoon Therapeutics, Inc... |
Former 10% Owner |
|
2021-04-13 |
4 |
AS |
$19.35 |
$37,806 |
I/I |
(1,943) |
3,223,567 |
0 |
% |
|
RDUS |
Radius Health Inc. |
10% Owner |
|
2011-05-17 |
4 |
D |
$0.01 |
$50,000 |
I/I |
(5,000,000) |
0 |
0 |
- |
|
HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
|
2021-04-12 |
4 |
AS |
$20.72 |
$52,460 |
I/I |
(2,496) |
3,225,510 |
0 |
% |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2005-09-14 |
4 |
S |
$2.45 |
$58,756 |
I/I |
(23,975) |
4,166,075 |
|
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-06-12 |
4 |
AS |
$30.00 |
$73,050 |
D/D |
(2,435) |
20,311 |
0 |
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
officerTitle |
|
2005-12-30 |
4 |
AS |
$2.30 |
$74,290 |
I/I |
(32,300) |
2,330,535 |
|
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-04-15 |
4 |
AS |
$30.00 |
$77,250 |
I/I |
(2,575) |
1,277,904 |
0 |
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2005-09-19 |
4 |
AS |
$2.41 |
$96,324 |
I/I |
(40,000) |
4,021,075 |
|
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-04-12 |
4 |
OE |
$2.69 |
$100,046 |
I/I |
37,192 |
1,317,671 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-04-12 |
4 |
S |
$29.30 |
$100,089 |
I/I |
(3,416) |
1,314,255 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-07-02 |
4 |
S |
$14.88 |
$116,786 |
I/I |
(7,847) |
1,833,597 |
|
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2005-09-13 |
4 |
S |
$2.44 |
$121,855 |
I/I |
(50,000) |
4,190,050 |
|
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
officerTitle |
|
2005-12-14 |
4 |
AS |
$2.30 |
$122,452 |
I/I |
(53,240) |
3,967,835 |
|
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2006-01-05 |
4 |
AS |
$2.36 |
$124,590 |
I/I |
(52,900) |
2,272,935 |
0 |
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Former 10% owner |
|
2005-08-15 |
4 |
S |
$2.61 |
$130,350 |
I/I |
(50,000) |
7,482,050 |
|
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
|
2023-05-22 |
4 |
OE |
$0.74 |
$131,919 |
D/D |
178,269 |
374,171 |
0 |
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
|
2023-05-22 |
4 |
S |
$1.88 |
$131,920 |
D/D |
(70,170) |
304,001 |
0 |
% |
|
OSCIQ |
Oscient Pharmaceuticals C... |
officerTitle |
|
2005-12-28 |
4 |
AS |
$2.33 |
$184,290 |
I/I |
(79,200) |
2,367,735 |
|
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-04-24 |
4 |
AS |
$30.04 |
$189,342 |
I/I |
(6,303) |
1,163,486 |
0 |
- |
|
107 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|